MA22195A1 - Procede de preparation de derives de l'acide benzoique destines au traitement des maladies associees aux lencotrienes - Google Patents
Procede de preparation de derives de l'acide benzoique destines au traitement des maladies associees aux lencotrienesInfo
- Publication number
- MA22195A1 MA22195A1 MA22441A MA22441A MA22195A1 MA 22195 A1 MA22195 A1 MA 22195A1 MA 22441 A MA22441 A MA 22441A MA 22441 A MA22441 A MA 22441A MA 22195 A1 MA22195 A1 MA 22195A1
- Authority
- MA
- Morocco
- Prior art keywords
- lencotrienes
- preparation
- treatment
- benzoic acid
- acid derivatives
- Prior art date
Links
- 150000001558 benzoic acid derivatives Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53439790A | 1990-06-07 | 1990-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA22195A1 true MA22195A1 (fr) | 1992-04-01 |
Family
ID=24129867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA22441A MA22195A1 (fr) | 1990-06-07 | 1991-06-03 | Procede de preparation de derives de l'acide benzoique destines au traitement des maladies associees aux lencotrienes |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0593464A1 (fr) |
| JP (1) | JPH07116150B2 (fr) |
| KR (1) | KR930700102A (fr) |
| CN (1) | CN1058015A (fr) |
| AU (1) | AU655428B2 (fr) |
| CA (1) | CA2083957A1 (fr) |
| FI (1) | FI925545A7 (fr) |
| HU (1) | HUT64747A (fr) |
| IL (1) | IL98387A0 (fr) |
| MA (1) | MA22195A1 (fr) |
| MX (1) | MX26167A (fr) |
| NZ (1) | NZ238426A (fr) |
| PL (1) | PL290587A1 (fr) |
| PT (1) | PT97913A (fr) |
| TW (1) | TW221809B (fr) |
| WO (1) | WO1991018601A1 (fr) |
| ZA (1) | ZA914322B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2119467A1 (fr) * | 1991-09-19 | 1993-04-01 | Pamela Anne Chambers | Composes pyridiniques pour le traitement des maladies associees aux leucotrienes |
| IL106156A0 (en) * | 1992-06-30 | 1993-10-20 | Smithkline Beecham Corp | Pyridinyl compounds |
| JP3181917B2 (ja) | 1992-06-30 | 2001-07-03 | スミスクライン・ビーチャム・コーポレイション | フェニルチオメチルピリジニルアルケノアート類の製造方法 |
| DE4224402A1 (de) * | 1992-07-21 | 1994-01-27 | Schering Ag | Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung |
| GR1001409B (el) * | 1992-10-15 | 1993-11-30 | Smithkline Beecham Corp | Ενώσεις για την ?εραπευτική αγωγή ασ?ενειών που έχουν σχέση με λευκοτριένια. |
| ES2065234B1 (es) * | 1992-10-27 | 1995-09-01 | Smithkline Beecham Corp | Compuestos para tratar enfermedades relacionadas con los leucotrienos. |
| US5643914A (en) * | 1993-03-02 | 1997-07-01 | Smithkline Beecham Corporation | Pharmaceutical pyridine compounds |
| US5929096A (en) * | 1996-02-29 | 1999-07-27 | Smithkline Beecham Corporation | Method for treating atopic dermatitis and contact dermatitis |
| EP0942903A1 (fr) * | 1996-09-26 | 1999-09-22 | Novartis AG | Acrylamides substitues par de l'aryle ayant une activite antagoniste du recepteur leucotriene b4 (ltb-4) |
| WO2005019434A2 (fr) | 2003-08-26 | 2005-03-03 | The Regents Of The University Of Colorado, A Body Corporate | Inhibiteurs de l'activite de la protease serine et leurs utilisations dans des methodes et preparations de traitement d'infections bacteriennes |
| US12078644B2 (en) * | 2018-06-22 | 2024-09-03 | Panasonic Holdings Corporation | Organic salt, hydroxy-radical sensor including same, and detection medium |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4056619A (en) * | 1975-09-08 | 1977-11-01 | Warner-Lambert Company | 1-Substituted-2-(2-pyridinyl)ethanone N-oxides |
-
1991
- 1991-05-31 KR KR1019920703091A patent/KR930700102A/ko not_active Abandoned
- 1991-05-31 AU AU81896/91A patent/AU655428B2/en not_active Ceased
- 1991-05-31 EP EP91911699A patent/EP0593464A1/fr not_active Ceased
- 1991-05-31 FI FI925545A patent/FI925545A7/fi not_active Application Discontinuation
- 1991-05-31 CA CA002083957A patent/CA2083957A1/fr not_active Abandoned
- 1991-05-31 JP JP3511468A patent/JPH07116150B2/ja not_active Expired - Lifetime
- 1991-05-31 HU HU9203867A patent/HUT64747A/hu unknown
- 1991-05-31 WO PCT/US1991/003772 patent/WO1991018601A1/fr not_active Ceased
- 1991-06-03 MA MA22441A patent/MA22195A1/fr unknown
- 1991-06-05 IL IL98387A patent/IL98387A0/xx unknown
- 1991-06-06 ZA ZA914322A patent/ZA914322B/xx unknown
- 1991-06-06 NZ NZ238426A patent/NZ238426A/en unknown
- 1991-06-06 TW TW080104434A patent/TW221809B/zh active
- 1991-06-07 PL PL29058791A patent/PL290587A1/xx unknown
- 1991-06-07 PT PT97913A patent/PT97913A/pt not_active Application Discontinuation
- 1991-06-07 MX MX2616791A patent/MX26167A/es unknown
- 1991-06-07 CN CN91104563A patent/CN1058015A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1058015A (zh) | 1992-01-22 |
| HU9203867D0 (en) | 1993-03-29 |
| FI925545A0 (fi) | 1992-12-07 |
| FI925545L (fi) | 1992-12-07 |
| HUT64747A (en) | 1994-02-28 |
| CA2083957A1 (fr) | 1991-12-08 |
| JPH07116150B2 (ja) | 1995-12-13 |
| EP0593464A1 (fr) | 1994-04-27 |
| KR930700102A (ko) | 1993-03-13 |
| IL98387A0 (en) | 1992-07-15 |
| TW221809B (fr) | 1994-03-21 |
| AU655428B2 (en) | 1994-12-22 |
| FI925545A7 (fi) | 1992-12-07 |
| PL290587A1 (en) | 1992-08-24 |
| PT97913A (pt) | 1992-03-31 |
| MX26167A (es) | 1994-02-28 |
| EP0593464A4 (fr) | 1993-02-12 |
| ZA914322B (en) | 1992-06-24 |
| JPH05507492A (ja) | 1993-10-28 |
| AU8189691A (en) | 1991-12-31 |
| WO1991018601A1 (fr) | 1991-12-12 |
| NZ238426A (en) | 1994-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RO75478A (fr) | PROCEDE POUR LA PREPARATION DES DERIVES D'ACIDE ALPROCEDE POUR LA PREPARATION DES DERIVES DE L'ACIDE ALPHA-PHENO0YPROïIONIQUE PHA-PHENOXYPROPIONIQUE | |
| MA22195A1 (fr) | Procede de preparation de derives de l'acide benzoique destines au traitement des maladies associees aux lencotrienes | |
| FR2554809B1 (fr) | Procede de preparation de l'acide acrylique | |
| BE890223A (fr) | Procede de preparation de derives de l'acide quinoleine-carboxylique | |
| MA22196A1 (fr) | Procede de preparation de derives de l'acide benzoique destines au traitement des maladies associees aux leucotrienes | |
| MA22649A1 (fr) | Procede de preparation de composes pour le traitement des maladies en rapport avec le leucotriene . | |
| MA22197A1 (fr) | Procede de preparation de derives de l'acide benzoique destines au traitement des maladies associees aux leucotrienes | |
| FR2723945B1 (fr) | Procede de fabrication de l'acide 2,5-furane dicarboxylique | |
| RO80004A (fr) | Procede pour la preparation des derives de l'ester de l'acide cyclopropancarboxylique | |
| FR2563208B1 (fr) | Procede de traitement des eaux par l'ozone | |
| RO83707A (fr) | Procede pour la preparation des esters chlormethyliques des derives de l'acide penycilanique | |
| PT74766B (fr) | Procede de preparation de nouveaux derives de l'acide cyclopropane carboxylique | |
| FR2666808B1 (fr) | Procede de preparation de l'acide adipique par hydrocarboxylation d'acides penteniques. | |
| FR2626884B1 (fr) | Procede de preparation de n-phosphonomethyl-imino-diacetique et de chlorure d'acide en resultant | |
| RO85386A (fr) | Procede pour la purification des derives d'acides phenoxybenzoiques | |
| RO84278A (fr) | Procede pour la preparation des derives de l'acide penycilanique | |
| FR2724378B1 (fr) | Procede de preparation de l'acide picrique | |
| FR2726557B1 (fr) | Procede de preparation d'acides carboxyliques par carbonylation en presence de rhodium | |
| FR2663024B1 (fr) | Procede de preparation d'acide (2-hydroxyphenyl) acetique. | |
| FR2669330B1 (fr) | Procede de preparation de l'acide betha-mercaptopropionique. | |
| RO81937A (fr) | Procede pour la preparation des derives de l'acide 7 beta-aminothiazolylacetamido-3-cephem-4-carboxylique | |
| FR2656528B1 (fr) | Formule combinee de cimetidine-pirenzepine pour le traitement des ulceres simples de l'estomac et des erosions et procede de traitement. | |
| FR2542758B1 (fr) | Procede de preparation de l'acide l-glutamique | |
| PT74813A (fr) | Procede de preparation de derives de l'acide 1,4-thiazane-carboxylique | |
| FR2589469B1 (fr) | Procede de preparation de l'acide valproique |